Evidence map›Paper›PMID 23000899›Full record

ArticleNature2012

In vivo genome editing using a high-efficiency TALEN system.

Victoria M Bedell, Ying Wang, Jarryd M Campbell, Tanya L Poshusta, Colby G Starker, Randall G Krug, Wenfang Tan, Sumedha G Penheiter, Alvin C Ma, Anskar Y H Leung and 6 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 499 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
499citing papers in PubMed, 1 pooled it
57.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

499 citing papers in PubMed, 1 synthesis or guideline pooled it, 918 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Engineering precision zebrafish alleles of human disease.bioRxiv : the preprint server for biology · 2025
    Article
  5. Review
  6. Article
  7. Genome editing in grain legumes for food security.Frontiers in genome editing · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. CRISPR/Cas9-MediatedInternational journal of molecular sciences · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Genes · 2024
    Article
  18. 3 Biotech · 2024
    Review
  19. Review
  20. Review

439 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Victoria M BedellDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Ying Wang
Jarryd M Campbell
Tanya L Poshusta
Colby G Starker
Randall G Krug
Wenfang Tan
Sumedha G Penheiter
Alvin C Ma
Anskar Y H Leung
Scott C Fahrenkrug
Daniel F Carlson
Daniel F Voytas
Karl J Clark
Jeffrey J Essner
Stephen C Ekker
Mayo Clinic · USUniversity of Minnesota · USIowa State University · USRecombinetics (United States) · USUniversity of Hong Kong · HKWinnMed · US

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
Systematic Vertebrate Functional GenomicsR01GM063904 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI EKKER, STEPHEN CARL · 2001 to 2025
$10.7M
In vitro and in vivo Signaling Mechanisms during Endothelial Tube FormationR01GM088424 · NIGMS · IOWA STATE UNIVERSITY · PI ESSNER, JEFFREY J · 2011 to 2015
$1.3M
Systematic Vertebrate Functional GenomicsR56GM063904 · NIGMS · MAYO CLINIC ROCHESTER · PI EKKER, STEPHEN CARL · 2009 to 2010
$611k
Developing zebrafish models to reveal interactions between stress and addictionR21DA032194 · NIDA · MAYO CLINIC ROCHESTER · PI CLARK, KARL J · 2011 to 2012
$394k
Development of Porcine Genetic Models of AtherosclerosisR41HL108440 · NHLBI · RECOMBINETICS, INC. · PI FAHRENKRUG, SCOTT CHRISTOPHER · 2011 to 2011
$318k
Molecular Mechanism of CCP1 Function in Zebrafish Kidney DevlopmentF30DK083219 · NIDDK · MAYO CLINIC ROCHESTER · PI BEDELL, VICTORIA MARIE · 2008 to 2012
$102k
NHLBI NIH HHS R41 HL108440NHLBI NIH HHS R41HL108440NIDA NIH HHS DA032194NIDA NIH HHS R21 DA032194NIDDK NIH HHS DK083219NIDDK NIH HHS F30 DK083219NIDDK NIH HHS P30 DK084567NIDDK NIH HHS P30DK084567NIGMS NIH HHS GM088424NIGMS NIH HHS GM63904NIGMS NIH HHS R01 GM063904NIGMS NIH HHS R01 GM088424NIGMS NIH HHS R56 GM063904
6 · The paper itself

Abstract

The zebrafish (Danio rerio) is increasingly being used to study basic vertebrate biology and human disease with a rich array of in vivo genetic and molecular tools. However, the inability to readily modify the genome in a targeted fashion has been a bottleneck in the field. Here we show that improvements in artificial transcription activator-like effector nucleases (TALENs) provide a powerful new approach for targeted zebrafish genome editing and functional genomic applications. Using the GoldyTALEN modified scaffold and zebrafish delivery system, we show that this enhanced TALEN toolkit has a high efficiency in inducing locus-specific DNA breaks in somatic and germline tissues. At some loci, this efficacy approaches 100%, including biallelic conversion in somatic tissues that mimics phenotypes seen using morpholino-based targeted gene knockdowns. With this updated TALEN system, we successfully used single-stranded DNA oligonucleotides to precisely modify sequences at predefined locations in the zebrafish genome through homology-directed repair, including the introduction of a custom-designed EcoRV site and a modified loxP (mloxP) sequence into somatic tissue in vivo. We further show successful germline transmission of both EcoRV and mloxP engineered chromosomes. This combined approach offers the potential to model genetic variation as well as to generate targeted conditional alleles.

Indexed as

AllelesAnimalsAttachment Sites, MicrobiologicalBase SequenceChromosomesDeoxyribonucleasesDeoxyribonucleases, Type II Site-SpecificDNA BreaksDNA, Single-StrandedGene TargetingGenetic EngineeringGenomeGenomicsGenotypeGerm-Line MutationMolecular Sequence DataCRF receptor type 2DeoxyribonucleasesDeoxyribonucleases, Type II Site-SpecificDNA, Single-StrandedGATATC-specific type II deoxyribonucleasesReceptors, Corticotropin-Releasing HormoneRNA, Messenger

Identifiers

PMID23000899
PMCPMC3491146
OpenAlexW1999068651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.